Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples